Literature DB >> 15772664

The first cleavage of the mouse zygote predicts the blastocyst axis.

Berenika Plusa1, Anna-Katerina Hadjantonakis, Dionne Gray, Karolina Piotrowska-Nitsche, Agnieszka Jedrusik, Virginia E Papaioannou, David M Glover, Magdalena Zernicka-Goetz.   

Abstract

One of the unanswered questions in mammalian development is how the embryonic-abembryonic axis of the blastocyst is first established. It is possible that the first cleavage division contributes to this process, because in most mouse embryos the progeny of one two-cell blastomere primarily populate the embryonic part of the blastocyst and the progeny of its sister populate the abembryonic part. However, it is not known whether the embryonic-abembryonic axis is set up by the first cleavage itself, by polarity in the oocyte that then sets the first cleavage plane with respect to the animal pole, or indeed whether it can be divorced entirely from the first cleavage and established in relation to the animal pole. Here we test the importance of the orientation of the first cleavage by imposing an elongated shape on the zygote so that the division no longer passes close to the animal pole, marked by the second polar body. Non-invasive lineage tracing shows that even when the first cleavage occurs along the short axis imposed by this experimental treatment, the progeny of the resulting two-cell blastomeres tend to populate the respective embryonic and abembryonic parts of the blastocyst. Thus, the first cleavage contributes to breaking the symmetry of the embryo, generating blastomeres with different developmental characteristics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15772664     DOI: 10.1038/nature03388

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  42 in total

Review 1.  Altered nuclear transfer: a way forward for embryonic stem cell research.

Authors:  William B Hurlbut
Journal:  Stem Cell Rev       Date:  2005-12       Impact factor: 5.739

Review 2.  Calcium at fertilization and in early development.

Authors:  Michael Whitaker
Journal:  Physiol Rev       Date:  2006-01       Impact factor: 37.312

Review 3.  Alternative sources of pluripotent stem cells: altered nuclear transfer.

Authors:  M L Condic
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

4.  Totipotency: what it is and what it is not.

Authors:  Maureen L Condic
Journal:  Stem Cells Dev       Date:  2014-02-12       Impact factor: 3.272

Review 5.  Understanding paternal genome demethylation through live-cell imaging and siRNA.

Authors:  Kazuo Yamagata; Yuki Okada
Journal:  Cell Mol Life Sci       Date:  2011-01-15       Impact factor: 9.261

6.  Non-invasive imaging of human embryos before embryonic genome activation predicts development to the blastocyst stage.

Authors:  Connie C Wong; Kevin E Loewke; Nancy L Bossert; Barry Behr; Christopher J De Jonge; Thomas M Baer; Renee A Reijo Pera
Journal:  Nat Biotechnol       Date:  2010-10-03       Impact factor: 54.908

Review 7.  The Eyes Absent proteins in development and disease.

Authors:  Emmanuel Tadjuidje; Rashmi S Hegde
Journal:  Cell Mol Life Sci       Date:  2012-09-13       Impact factor: 9.261

8.  Transgene delivery via intracellular electroporetic nanoinjection.

Authors:  Aubrey M Wilson; Quentin T Aten; Nathan C Toone; Justin L Black; Brian D Jensen; Susan Tamowski; Larry L Howell; Sandra H Burnett
Journal:  Transgenic Res       Date:  2013-03-27       Impact factor: 2.788

9.  Assisted fertilization and embryonic axis formation in higher primates.

Authors:  Karolina Piotrowska-Nitsche; Shang-Hsun Yang; Heather Banta; Anthony W S Chan
Journal:  Reprod Biomed Online       Date:  2009-03       Impact factor: 3.828

10.  Functional genomics of 5- to 8-cell stage human embryos by blastomere single-cell cDNA analysis.

Authors:  Amparo Galán; David Montaner; M Eugenia Póo; Diana Valbuena; Verónica Ruiz; Cristóbal Aguilar; Joaquín Dopazo; Carlos Simón
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.